Liver Metastases of Colorectal Cancer: Medical Treatments

Lara Maria Pasetto, Elena Rossi, Silvio Monfardini

Research output: Contribution to journalArticlepeer-review


Colorectal adenocarcinoma ranks second as a cause of death due to cancer in the Western world. Liver metastases form the main cause of death in patients with colorectal cancer. Already at the time of the primary tumor, 15-25% of the patients present with liver metastases, while another 20% will develop these metastases following treatment of the colorectal primary. Without any treatment the median survival after the detection of liver metastases is approximately 9 months, depending on the extent of the disease at the time of diagnosis. This paper examines the factors pertinent to clinical trial designed for metastatic colorectal cancer and reviews the existing data supporting adjuvant and neoadjuvant therapy for potentially resectable disease and chemotherapy in the inoperable disease.

Original languageEnglish
Pages (from-to)4245-4256
Number of pages12
JournalAnticancer Research
Issue number5 B
Publication statusPublished - Sep 2003


  • Chemotherapy
  • Colorectal cancer
  • Liver metastases
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Liver Metastases of Colorectal Cancer: Medical Treatments'. Together they form a unique fingerprint.

Cite this